Involvement of DPPIV/CD26 in epithelial morphology and suppressed invasive ability in ovarian carcinoma cells

Annals of the New York Academy of Sciences

Volumn 1086, Issue , 2006, Pages 233-240

  Kajiyama, Hiroaki ^a   Shibata, Kiyosumi ^a   Terauchi, Mikio ^a   Ino, Kazuhiko ^a   Nawa, Akihiro ^a   Kikkawa, Fumitaka ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

DPPIV CD26; Invasion; MMP 2; Morphology; Ovarian carcinoma

Indexed keywords

DIPEPTIDYL PEPTIDASE IV; GELATINASE A; SMOOTH MUSCLE ACTIN; VIMENTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; CANCER CELL; CELL MIGRATION; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION ANALYSIS; EPITHELIUM; FEMALE; HUMAN; HUMAN CELL; MORPHOLOGY; MOUSE; NONHUMAN; OVARY CARCINOMA; PROTEIN EXPRESSION; PROTEIN FUNCTION; ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BIOSYNTHESIS; CANCER INVASION; CELL MOTION; CELL SHAPE; ENZYMOLOGY; EPITHELIUM CELL; MESODERM; METABOLISM; NUDE MOUSE; OVARY TUMOR; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

ANIMALS; ANTIGENS, CD26; CELL LINE, TUMOR; CELL MOVEMENT; CELL SHAPE; EPITHELIAL CELLS; FEMALE; HUMANS; MATRIX METALLOPROTEINASE 2; MESODERM; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM INVASIVENESS; OVARIAN NEOPLASMS; VIMENTIN;

EID: 34447526600     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1377.007     Document Type: Conference Paper

References (14)

1. FLEISCHER, B. 1994. CD26: a surface protease involved in T-cell activation. Immunol. Today 15: 180-184.
2. MIZUTANI, S., S. SUMI, O. NARITA, et al. 1985. Purification and properties of human placental dipeptidyl peptidase IV. Nippon Sanka Fujinka Gakkai Zasshi 37: 769-775.
3. HEIKE, M., U. MOBIUS, A. KNUTH, et al. 1988. Tissue distribution of the T cell activation antigen Ta1. Serological, immunohistochemical and biochemical investigations. Clin. Exp. Immunol. 74: 431-434.
4. MENTLEIN, R. 1999. Dipeptidyl-peptidase IV (CD26) - role in the inactivation of regulatory peptides. Regul. Pept. 85: 9-24.
5. HANSKI, C., T. HUHLE & W. REUTTER. 1985. Involvement of plasma membrane dipeptidyl peptidase IV in fibronectin-mediated adhesion of cells on collagen. Biol. Chem. Hoppe. Seyler 366: 1169-1176.
6. LOSTER, K., K. ZEILINGER, D. SCHUPPAN, et al. 1995. The cysteine-rich region of dipeptidyl peptidase IV (CD 26) is the collagen-binding site. Biochem. Biophys. Res. Commun. 217: 341-348.
7. MORIMOTO, C., C.I. LORD, C. ZHANG, et al. 1994. Role of CD26/dipeptidyl peptidase IV in human immunodeficiency virus type 1 infection and apoptosis. Proc. Natl. Acad. Sci. U S A. 91: 9960-9964.
8. CHENG, H.C., M. ABDEL-GHANY, R.C. ELBLE, et al. 1998. Lung endothelial dipeptidyl peptidase IV promotes adhesion and metastasis of rat breast cancer cells via tumor cell surface-associated fibronectin. J. Biol. Chem. 273: 24207-24215.
9. PETHIYAGODA, C.L., D.R. WELCH & T.P. FLEMING. 2000. Dipeptidyl peptidase IV (DPPIV) inhibits cellular invasion of melanoma cells. Clin. Exp. Metastasis 18: 391-400.
10. AYTAC, U., F.X. CLARET, L. HO, et al. 2001. Expression of CD26 and its associated dipeptidyl peptidase IV enzyme activity enhances sensitivity to doxorubicininduced cell cycle arrest at the G(2)/M checkpoint. Cancer Res. 61: 7204-7210.
11. KAJIYAMA, H., F. KIKKAWA, T. SUZUKI, et al. 2002. Prolonged survival and decreased invasive activity attributable to dipeptidyl peptidase IV overexpression in ovarian carcinoma. Cancer Res. 62: 2753-2757.
12. KAJIYAMA, H., F. KIKKAWA, E. KHIN, et al. 2003. Dipeptidyl peptidase IV overexpression induces up-regulation of E-cadherin and tissue inhibitors of matrix metalloproteinases, resulting in decreased invasive potential in ovarian carcinoma cells. Cancer Res. 63: 2278-2283.
13. WESLEY, U.V., A.P. ALBINO, S. TIWARI, et al. 1999. A role for dipeptidyl peptidase IV in suppressing the malignant phenotype of melanocytic cells. J. Exp. Med. 190: 311-322.
14. LUO, J., D.M. LUBAROFF & M.J. HENDRIX. 1999. Suppression of prostate cancer invasive potential and matrix metalloproteinase activity by E-cadherin transfection. Cancer Res. 59: 3552-3556.